Transcure Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.10 M
- Revenue Growth 54.41%
- Profit Growth 127.05%
- Ebitda 90.65%
- Net Worth 24.75%
- Total Assets 56.94%
About Transcure Therapeutics
Transcure Therapeutics Private Limited (TTPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 October 2005 and has a history of 19 years and three months. Its registered office is in Ludhiana, Punjab, India.
The Corporate was formerly known as Sefcare Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.10 M.
Vivek Srivastava and Davinder Garg serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230PB2005PTC029115
-
Company No.
029115
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Oct 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Transcure Therapeutics Private Limited offer?
Transcure Therapeutics Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Nutraceuticals & Dietary Supplements, Dietary Supplements, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Transcure Therapeutics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Srivastava
|
Director | 23-Jan-2017 | Current |
|
Davinder Garg
|
Director | 28-Oct-2008 | Current |
Financial Performance of Transcure Therapeutics.
Transcure Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.41% increase. The company also saw a substantial improvement in profitability, with a 127.05% increase in profit. The company's net worth Soared by an impressive increase of 24.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Transcure Therapeutics?
In 2022, Transcure Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.10 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2024 | Others | ₹1.60 M | Open |
| 09 May 2024 | Others | ₹1.50 M | Open |
| 10 Oct 2023 | Others | ₹1.00 M | Open |
How Many Employees Work at Transcure Therapeutics?
Unlock and access historical data on people associated with Transcure Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transcure Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transcure Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
